A new study found that a drug recently approved to treat type 2 diabetes and kidney disease in patients with additional ...
The dual SGLT1/2 inhibitor sotagliflozin (Inpefa) reduced the risk for myocardial infarction (MI) and stroke in high-risk ...
Sotagliflozin, a drug recently approved by the Food and Drug Administration to treat type 2 diabetes and kidney disease with ...
Reaching out for help is often a difficult step. A novel approach to health services in Milwaukee County is improving ...
Imagine seeing a furry, four-legged animal that meows. Mentally, you know what it is, but the word "cat" is stuck on the tip ...
and to investigate its predictive role in stroke recurrence after optimal medical treatment. Methods Consecutive patients with ischemic stroke within 30 days attributed to 50%–99% ICAS were ...
Patients were followed up for stroke recurrence within 1 year postprocedure, with survival analysis used to examine the relationship between procedure type and recurrence. Results Between March and ...
The medical institution initially earned the certification in 2022, and is required to recertify annually. Pullman Regional ...
10d
The Healthy @Reader's Digest on MSNNew Research: This Surprising Medication Could Lower Stroke Risk Up to 50%A leading cardiology doctor says this reinforces the importance of studying gender-specific health trends in research.
In this study, we evaluate the effect of language preference on door to imaging (DIT ... enrolled in the Video-based Intervention to reduce Treatment and Outcome Disparities in Adults Living with ...
Wait for an ambulance that will begin life-saving treatment on the way to the hospital. They will also call ahead to the emergency room where staff will be waiting for you. When a stroke patient ...
HealthDay News — In clinical practice guidelines jointly issued by the U.S. Department of Veterans Affairs and U.S. Department of Defense and published online Jan. 21 in the Annals of Internal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results